ChemoCentryx Inc. (CCXI) Shares Up 1.5%
ChemoCentryx Inc. (NASDAQ:CCXI)’s share price shot up 1.5% during mid-day trading on Wednesday . The stock traded as high as $4.80 and last traded at $4.68, with a volume of 59,099 shares trading hands. The stock had previously closed at $4.61.
Several research firms recently issued reports on CCXI. JPMorgan Chase & Co. reaffirmed a “buy” rating and issued a $11.00 price objective on shares of ChemoCentryx in a research report on Tuesday, August 9th. Cowen and Company reaffirmed a “hold” rating on shares of ChemoCentryx in a research report on Thursday, May 19th. Finally, Zacks Investment Research cut ChemoCentryx from a “buy” rating to a “hold” rating in a research report on Monday, May 16th.
The firm’s 50-day moving average is $4.57 and its 200-day moving average is $3.83. The stock’s market cap is $245.50 million.
ChemoCentryx, Inc (ChemoCentryx) is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing orally-administered therapeutics to treat orphan and rare diseases, autoimmune diseases, inflammatory disorders and cancer. It targets the chemoattractant system, which is a network of molecules, including chemokine ligands and their associated receptors, as well as related chemoattractant receptors.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.